Helen Sabzevari Precigen, Inc. (PGEN) insider trading activity

Helen Sabzevari is President and CEO of PRECIGEN, INC.. Currently has a direct ownership of 3.32 Million shares of PGEN, which is worth approximately $5.44 Million. The most recent transaction as insider was on May 13, 2021, when has been sold 47,433 shares (Common Stock) at a price of $6.4 per share, resulting in proceeds of $303,571. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.32M

20.22% 3M change

49.34% 12M change

Total Value Held $5.44 Million

Helen Sabzevari Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 13 2021	SELL Open market or private sale	$303,571 $6.4 p/Share	47,433 Reduced 6.3%	705,057 Common Stock
May 12 2021	BUY Exercise of conversion of derivative security	-	97,276 Added 11.45%	752,490 Common Stock
Jan 06 2021	SELL Open market or private sale	$2,319,601 $8.92 p/Share	260,045 Reduced 28.41%	655,214 Common Stock
Jan 05 2021	SELL Open market or private sale	$95,462 $10.56 p/Share	9,040 Reduced 2.13%	415,259 Common Stock
Jan 05 2021	BUY Exercise of conversion of derivative security	-	500,000 Added 35.33%	915,259 Common Stock
Jan 04 2021	SELL Open market or private sale	$53,635 $10.16 p/Share	5,279 Reduced 1.28%	406,632 Common Stock
Jan 04 2021	BUY Exercise of conversion of derivative security	-	17,667 Added 4.0%	424,299 Common Stock
Jan 02 2021	BUY Exercise of conversion of derivative security	-	9,766 Added 2.32%	411,911 Common Stock

Also insider at

KNTE

Kinnate Biopharma Inc. Healthcare

Helen Sabzevari

President and CEO

Germantown, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PGEN shares.

Notify only if

Value

Insider Trading

Get notified when an Precigen, Inc. insider buys or sells PGEN shares.

Notify only if

Operation

Value

Type

News

Receive news related to PRECIGEN, INC.

Track Activities on PGEN

Account